Target intelligence / Profile preview

Flavin containing dimethylaniline monoxygenase 9, pseudogene (FMO9P)

Target: FMO9P
Molecular classification: Pseudogene, Noncoding RNA gene, Other

Overview

FMO9P is officially known as flavin containing dimethylaniline monoxygenase 9, pseudogene (RP11-45J16.2). It represents a nonfunctional derivative of the FMO gene family but does not encode a functional enzyme or protein product[4]. Pseudogenes like FMO9P are often transcriptionally silent or produce RNA that may regulate related protein-coding genes by acting as microRNA decoys, producing short interfering RNAs, or modulating mRNA stability of parent genes[2][3][4]. Although some pseudogenes have demonstrable biological regulatory activities—e.g., influencing cancer progression or metabolic regulation—there is no evidence that FMO9P itself serves as a direct or validated therapeutic target. Pseudogenes can complicate genetic analyses due to sequence similarity with functional genes and may participate in noncoding RNA regulatory networks in human cells[2][3][4].

Other names: FMO9PRP11-45J16.2

Biological functions

Regulation of gene expression via RNA interference (possible regulation through siRNA or miRNA sponge activity, as documented for other pseudogenes)Possible modulation of mRNA stability of related genes

Disease associations

Other (Regulation in cancer progression by acting as microRNA decoys or affecting stability of mRNAs for oncogenes or tumor suppressors, as pseudogenes in general have been implicated)There is no specific disease directly linked to FMO9P, but general pseudogene dysregulation is associated with cancer and metabolic disorders in some contexts

Beyond the preview

Go deeper on Flavin containing dimethylaniline monoxygenase 9, pseudogene (FMO9P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavin containing dimethylaniline monoxygenase 9, pseudogene (FMO9P).

Explore the full profile